曲美替尼联合达拉非尼对比维莫非尼治疗伴有BRAF V600突变的转移性黑色素瘤的成本-效用分析
周晓莺, 孙国君
Cost-utility analysis of trametinib plus dabrafenib versus vemurafenib in the treatment of metastatic melanoma with BRAF V600 mutation
ZHOU Xiao-ying, SUN Guo-jun
中国医院药学杂志
.
2022, (17): 1830
-1833
.
DOI: 10.13286/j.1001-5213.2022.17.17
